Status:
COMPLETED
Clinical Application of Novel Panels for Early Precision Diagnosis and Relapse Prediction in High-risk Leukemia
Lead Sponsor:
Zhongda Hospital
Conditions:
Leukemia, Acute
Eligibility:
All Genders
14-75 years
Brief Summary
Based on the investigator's previous data on risk classification for acute leukemia,the investigators will design a set of panels to detect the gene expression and genomic variants (SNPs, mutation, in...
Detailed Description
patient eligibility criteria: newly diagnosed acute leukemia patients with clinical high-risk markers, reflactory and relapsed patients.
Eligibility Criteria
Inclusion
- Newly diagnostic acute lymphoblastic leukemia Be willing to start treatment
Exclusion
- chronic leukemia
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03297476
Start Date
December 1 2017
End Date
December 31 2020
Last Update
March 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Hematology, Zhongda Hospital Southeast University, Institute of Hematology Southeast University
Nanjing, Jiangsu, China, 210009